New laser zaps dry eye by targeting blood vessels on eyelids
NCT ID NCT04425551
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a gentle laser (micropulse) on 30 people with dry eye from meibomian gland dysfunction. The laser targets tiny blood vessels on the eyelid edge to reduce inflammation and improve tear quality. Researchers measured tear stability and symptom scores to see if the treatment helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
First Department of Ophthalmology, National and Kapodistrian University of Athens, Athens, Greece
Athens, Greece
-
Naval Hospital of Athens
Athens, 11521, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can insulin eye drops quench dry eyes?
- Can a new eye drop soothe severe dry eye?
- New imaging tools put to the test for measuring dry eye treatment effects
- Could your own blood cure dry eye? plasma drops put to the test
- Could a special screen light reduce tired eyes and dryness?
- Nasal spray could make contact lenses more comfortable